Ethanolaminephosphate Side Chain Added to Glycosylphosphatidylinositol (GPI) Anchor by Mcd4p Is Required for Ceramide Remodeling and Forward Transport of GPI Proteins from Endoplasmic Reticulum to Golgi by Zhu, Yonghua et al.
ht
tp
://
do
c.
re
ro
.c
h
1
ETHANOLAMINEPHOSPHATE SIDE CHAIN ADDED TO
GPI ANCHOR BY MCD4P IS REQUIRED FOR CERAMIDE
REMODELING AND FORWARD TRANSPORT OF GPI
PROTEINS FROM ER TO GOLGI
Yonghua Zhu,* Christine Vionnet and Andreas Conzelmann
Department of Medicine/Biochemistry, University of Fribourg, Switzerland
Running title: ethanolaminephosphate on yeast GPI anchors
Corresponding author e-mail: andreas.conzelmann@unifr.ch
Dr. A. Conzelmann, Division of Biochemistry, Chemin du Musée 5, CH-1700 Fribourg, Switzerland.
Tel. ++41 26 300 8630. Fax ++41 26 300 9735.
* Current address: Institute of life science and Biotechnology, Hunan University, 410082 Changsha city,
P.R.China
Glycosylphosphatidylinositol (GPI) anchors
of mammals as well as yeast contain
ethanolaminephosphate side chains on the
1-4 and the 1-6 linked mannoses of the
anchor core structure (protein-CO-NH-
(CH2)-PO4-6Man1-2Man1-6Man1-
4GlcNH2-inositol-PO4-lipid). In yeast, the
ethanolaminephosphate on the 1-4 linked
mannose is added during the biosynthesis of
the GPI lipid by Mcd4p. MCD4 is essential
because Gpi10p, the mannosyltransferase
adding the subsequent 1-2-linked
mannose, requires substrates with an
ethanolaminephosphate on the 1-4 linked
mannose. The Gpi10p ortholog of T. brucei
has no such requirement. Here we show that
the overexpression of this ortholog rescues
mcd4 cells. Phenotypic analysis of the
rescued mcd4 cells leads to the conclusion
that the ethanolaminephosphate on the 1-4
linked mannose, beyond being an essential
determinant for Gpi10p, is necessary for an
efficient recognition of GPI lipids and GPI
proteins by the GPI transamidase, for the
efficient transport of GPI anchored proteins
from ER to Golgi and for the physiological
incorporation of ceramides into GPI
anchors by lipid remodeling. Furthermore,
mcd4 cells have a marked defect in axial
bud site selection while this process is
normal in gpi7 and gpi1. This suggests that
also axial bud site selection specifically
depends on the presence of the
ethanolaminephosphate on the 1-4 linked
mannose.
Introduction
The carbohydrate structure linking the C-
terminal end of glycosylphosphatidylinositol
(GPI) anchored proteins to the lipid moiety is
identical in GPI anchors from all organisms
analyzed so far, but the GPI anchors from
various species differ widely with regard to the
side chains attached to this core structure as
well as the lipid moieties of the anchor (1, 2).
T h i s r e p o r t c o n c e r n s t h e
ethanolaminephosphate (EtN-P) side chain,
which is often present on mannose 1 of the
core structure (Man1 in Fig. 1). Indeed, an
EtN-P is found on Man1 of GPI lipids and GPI
proteins in mammals, S a c c h a r o m y c e s
cerevisiae and Torpedo californica, and
possibly Candida albicans, but is not found in
other organisms such as Trypanosoma brucei,
Leishmania major or Plasmodium falciparum
(3-7). The EtN-P-transferase transferring EtN-
P to Man1 is encoded by MCD4 in yeast and
its ortholog PIG-N in mammals (Fig. 1)(8, 9).
Phosphatidylethanolamine (PE) serves as a
donor of the EtN-P group (10). Yeast also
possesses two MCD4 homologs, GPI7 and
GPI13, which are involved in the transfer of
EtN-P to Man2 and Man3, respectively (Fig.
1). MCD4 is essential and can be inhibited by
YW3548 (6). Addition of this inhibitor or the
depletion of Mcd4p arrest the growth of yeast
cells and lead to the accumulation of the
abnormal GPI lipid M2* (Man1-6Man1-
4GlcNH2-inositol-PO4-lipid), indicating a
problem with the addition of Man3 (Fig. 1)(6,
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7, 9, 11). This suggested that Gpi10p strongly
prefers substrates carrying an EtN-P
substituent on Man1. Indeed, overexpression
of Mcd4p can improve the growth of yeast
cells in the presence of low concentrations of
YW3548, while overexpression of Gpi10p is
comparatively inefficient (9, 11). While these
data indicate that Mcd4p helps Gpi10p by
providing an optimal substrate, they can't rule
out the possibility that MCD4 would influence
the function of Gpi10p in another way, e.g. by
regulating PE levels in the ER or by
channeling substrate into Gpi10p or stabilizing
Gpi10p.
There indeed is a genetic link between MCD4
and PE biosynthesis: The mcd4-P301L and
mcd4-174 alleles render cells temperature
sensitive (ts) when combined with psd1, the
later eliminating the phosphatidylserine
decarboxylase, by which the bulk of PE is
made. The mcd4-P301L mutation was claimed
to not affect GPI biosynthesis. Temperature
sensitivity of mcd4 psd1 mutants could be
reverted by the addition of ethanolamine or
choline or ethanolamine and sorbitol to the
media (12). Temperature sensitivity of another
mcd4 allele named fsr2-1 is suppressed by
overexpression of PSD1 , PSD2 or ECM33
(13).
Mutations in MCD4 also show several other,
quite specific phenotypes, which may not be
related to its effect on GPI biosynthesis.
Mutants in MCD4 (mitotic check point
dependent 4) were found to suffer from
delayed bud emergence and an inability to
polarize secretion to the bud tip or septum,
thus becoming dependent on a checkpoint
delaying mitosis until a bud is formed (14).
Buds of mcd4-174 are small, misshapen and
contain many aberrant membrane structures
(8). Certain mcd4 mutants also activate one
branch of the hyperosmotic response pathway
and are more resistant to high concentrations
of Cu2+ than wt cells (15).
GPI lipids and GPI anchors of Trypanosoma
brucei do not contain any EtN-P side chains
and thus, their presence certainly will not be
required by the T. brucei GPI10 ortholog (3,
16). In order to test the relationship between
MCD4 and GPI10 and explore the various
functions of MCD4 more closely, we tested if
it was possible to overcome the lethality of the
mcd4 deletion by introducing T. brucei
Gpi10p into mcd4 cells. The results show that
in this way it is possible to create a cell, in
which all functions of Mcd4p are lost while
some GPI biosynthesis is preserved.
Experimental Procedures
Strains, growth conditions and materials
Saccharomyces cerevisiae strains used were
MCD4/mcd4, MATa /  his31/his31
leu20/leu20 lys20/LYS2 MET17/met170
ura30/ura30 YKL165c::kanMX4/YKL165c
(EUROSCARF); T 1 , MATa his31 leu20
ura30 p425-TbGPI10; T 2 , M A This31
leu20 ura30 met170 p425-TbGPI10; T3,
MATa his31 leu20 ura30 mcd4::kanMX4
p425-TbGPI10; T4 , MAT his31 leu20
ura30 met170 mcd4::kanMX4 p 4 2 5 -
TbGPI10; MCD4 (17A-H42), MATa trp1-289
ura3-52 leu2 and mcd4ts (521-17A-H42),
M A T a trp1-289 ura3-52 leu2 ssu21 (17);
MKY3, MAT trp1 lys2 ura3 leu2 his3 psd1-
1::TRP1 mcd4-P301L etn- t s (ethanolamine
dependent at 37°C) and MKY13, MATa arg4
ura3 his3 trp1 leu2 psd1-1::TRP1 mcd4-174
(12); BY4742, MAT his31 leu20 lys20
ura30 ( E U R O S C A R F ) ; y a p 3  ,
Y L R 1 2 0 c : : k a n M X 4 i n B Y 4 7 4 2
(EUROSCARF); gpi8 (164-1C) MAT h i s 4
leu2; gpi8 sec18 (FBY91), gpi8-1 sec18-1ts
leu2-3,112 (7); gpi1 MATa u r a 3 - 5 2
his3::hisG gpi1::URA3 pRS425-CCW12HA;
gpi1, MAT ura3-52 lys2 gpi1 (isolated as
cwh4 by Frans Klis) ; g p i 7  ,
Y J L 0 6 2 w : : k a n M X 4 in BY4742
(EUROSCARF); elo3 , YLR372W::kanMX4
in BY4742 (EUROSCARF). Cells were grown
on rich medium (YPD) or minimal media (SD)
(18) containing 2% glucose (D) as a carbon
source and uracil (U), adenine (A) and amino
acids (aa) as required at 30°C. Methionine was
added at 10 mg/L (38 μM), so that the MET17
promoter was almost fully active.
Oligonucleotide synthesis and DNA
sequencing services were provided by
MICROSYNTH, Balgach, Switzerland.
Verification of deletions was done by PCR as
shown if Fig. 2C using the following
p r i m e r s : F 1 = 5 ' -
ATGTGGAACAAAACCAGAAGGAC-3', F2
= 5'-CACACACGGTGGATCCTGTACAC-3',
R1 = 5'-GCTCGATGGAAGATTGCG-3', R2
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= 5'-AGCAATCATAGCAACATGACC-3',
R3 = 5'-CAAGGAGGGTATTCTGGGC-3', F4
= 5 ' -
CGCGGATCCATGCCGTGGTGGTTGATTT
C - 3 ' , R 4 = 5 ' -
CGGAATTCCGTCACTTCGTCACCTTGAC
CC.
Construction of yeast vectors
The T. brucei GPI10 behind the M E T 1 7
promoter on a multicopy plasmid (p425-
TbGPI10, LEU2) was the kind gift of Howard
Riezman and Taroh Kinoshita (16). The
promoter and open reading frame of MCD4
was amplified by PCR and inserted into
YEp352 to yield pBF639 (URA3). Sequence
verification showed a point mutation I387T (at
DNA level: T1160C), but the plasmid was able
to fully complement mcd4 mutants.
Cell extraction and Western blotting
Proteins were extracted by incubating cells for
5 min in NaOH and boiling at 95°C in
reducing sample buffer (19). Alternatively,
cells were broken by glass beads in TEPI
buffer (100 mM Tris-HCl, pH 7.5, 10 mM
EDTA, 30 μg/ml of each, leupeptine, antipain,
and pepstatin, 2 mM PMSF) at 4°C, and the
lysate was directly solubilized in octyl--
glucoside (50 mM) at 4°C for 30 min. After
solubilization, the extracts were centrifuged at
16'000 g for 30 min at 4°C and the supernatant
was precipitated with trichloroacetic acid
(TCA) and boiled in reducing sample buffer as
above. In other experiments, cells were broken
by glass beads in TEPI buffer, the lysate was
directly treated with DNAse (Fluka 31136) for
45 min at room temperature, then the lysate
was solubilized with Triton X-114 (1%) at 4°C
for 30 min. After solubilization, insoluble
material was removed by centrifugation at
16 '000 g x 5 min at 4°C. The supernatants
were separated into detergent (D) and aqueous
(A) phases at 37°C followed by mild
centrifugation. The detergent (D) and aqueous
(A) fractions were then precipitated with TCA.
For treatment with phosphatidylinositol-
specific phospholipase C (PI-PLC), the
detergent phase was diluted and treated with
PI-PLC from B. cereus (Sigma P 5542 or
Funakoshi Pharm BR-05) using 1 U /ml at
37°C for 2 h with occasional shaking. After a
further phase separation the detergent and
aqueous phases were precipitated with TCA
and processed as above. As primary antibodies
we used purified mouse anti-CPY
(MOLECULAR PROBES), rabbit anti-Yap3p
(a kind gift from Dr. Niahm Cawley) and
rabbit anti-Gas1p, made in the lab. As
secondary antibodies for blots we used
fluorescent goat anti-mouse IgG conjugated to
AlexaFuor680 or goat anti-rabbit IgG
conjugated to IRDye800 and fluorescence was
measured with the Odyssey Imaging system
(LI-COR). Alternatively, blots were revealed
with goat anti-rabbit IgG conjugated to
peroxidase and using ECL technology
(Amersham Biosciences).
Analysis of GPIs
GPI lipids were analyzed by metabolic
labeling of yeast cells with [3H]myo-inositol
and labeling of yeast microsomes with UDP-
[3H]GlcNAc as described before (7). Head
groups of GPI lipids were analyzed with HF
using the protocol originally developed by
Mike Ferguson (7) and remodeling of lipids on
GPI anchors was analyzed by liberating anchor
lipids from anchor peptides using HNO2 as
described (20).
Microscopy
To stain cells with calcofluor white, cells were
kept in continuous exponential growth for >10
generations, one A600 unit of cells was washed
with water, stained in calcofluor white (1
mg/ml) for 10 to 20 min at room temperature,
washed again and observed under the
microscope.
Results
T. brucei Gpi10p can rescue
viability of mcd4 cells
The multicopy vector p425-TbGPI10
harboring TbGPI10 behind the M E T 1 7
promoter was introduced into a
mcd4::KanMX/MCD4 heterozygous diploid
strain. The transformed diploid was sporulated
and tetrads were dissected. Very few complete
tetrads were obtained. Fig. 2A shows a
complete tetrad, in which geneticin resistance
and methionine auxotrophy segregated 2:2
(Fig. 2B), suggesting that spores T3 and T4
were m c d 4 : :K a n MX. PCR analysis
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confirmed the mcd4::KanMX genotype and
the presence of the p425-TbGPI10 plasmid in
T3 and T4 (Fig. 2C). The mcd4::KanMX
strains grew rather slowly. The generation
times at 30°C in liquid SDaaUA medium of
T1, T2, T3, T4, were 2.48, 2.39, 5.25 and 6.03
hours, respectively. The corresponding
generation times in YPDUA were 1.53, 1.61,
7.38 and 6.15 hours, respectively (not shown).
The M E T 1 7 promoter driving TbGPI10
expression is 3 - 5 times more active in the
absence of methionine (21). Omission of
methionine from minimal medium to achieve a
higher expression of TbGPI10 did not enhance
the growth rate of MET17 mcd4::KanMX
cells (not shown). On plates the
mcd4/TbGPI10 cells grew at almost the same
rate at 24 °C, 30°C and 37°C but they were
inositol dependent at 37°C (Fig. 2D). The
growth rate of mcd4/TbGPI10 cells on plates
at 37°C was also increased by 1M sorbitol and
slightly improved by ethanolamine, and the
greatest effect on colony size was observed
when all these ingredients were combined (Fig.
2D). Sorbitol has been reported to rescue
certain mcd4 mutants (12, 22). However, the
p425-TbGPI10 plasmid did not allow various
temperature sensitive mcd4 strains (ssu21,
mcd4-174, mcd4-P301L) to grow at restrictive
temperature (37°C)(not shown), neither in the
presence nor absence of ethanolamine. This
may suggest a possible dominant negative
effect of these mutant alleles.
The m c d 4  / T b G P I 1 0 cells
accumulate an abnormal GPI lipid
To investigate the structure of the GPI lipids
made by mcd4/TbGPI10 strains, we labeled
intact cells with [3H]inositol and analyzed the
lipid extracts by TLC and fluorography. In
wild type (wt) cells, no GPI lipids can be
detected in this way, but certain mutants
deficient in GPI biosynthesis or GPI addition
to proteins were shown to accumulate
significant amounts of labeled biosynthetic
intermediates (23). As seen in Fig. 3A, there is
an abnormal lipid accumulating in T3 and T4
mcd4/TbGPI10 strains, which is absent from
the T1 and T2 MCD4 strains (lanes 5, 6 vs. 2,
3). This lipid was named M4* as it has about
the same mobility as M4/2, which is one of the
several abnormal GPI lipids accumulating in
GPI transamidase mutants such as gpi8 sec18
(Fig. 3A, lane 7). While CP2 contains an EtN-
P group on Man1, Man2 and Man3 (Fig. 1),
gpi7 mutants accumulate M4/1 (Fig. 3A, lane
4), which lacks the EtN-P on Man2, while
preserving the EtN-P's on Man1 and Man3
(23). The head group of M4* could be released
by mild deacylation followed by PI-PLC
treatment and, as shown in Fig. 3B, treatment
of the liberated head group with HF and acetic
anhydride yielded a Man4-GlcNAc-Inositol
fragment. This partial analysis of lipid M4* is
compatible with the idea that M4* is a CP2
lacking EtN-P on Man1, thus being the most
mature GPI lipid we theoretically can expect in
mcd4 /TbGPI10 cells (Fig. 1). When the
mcd4-P301L (MKY3) or mcd4-174 (MKY13)
strains were labeled with [3H]inositol at 37°C,
neither M4* nor any other late GPI
intermediate were detectable as reported before
(12) (not shown). Moreover, this was also true
when these cells expressed TbGPI10 and
independent of the presence or absence of
ethanolamine in the labeling medium (not
shown). This again points to a possible
dominant negtive effect of these mcd4 alleles.
To further investigate the GPI biosynthesis
pathway we prepared microsomes and
incubated them with UDP-[3H]GlcNAc. As
shown in Fig. 3C, the mature GPI lipid CP2
(Fig. 1) was not detectable in mcd4/TbGPI10
strains T3 and T4 (lanes 3, 4). However,
mcd4/TbGPI10 strains showed an abnormal
accumulation of lipid 4c (Fig. 3C, lanes 3, 4;
open triangles), which also accumulates in a
temperature sensitive mcd4 mutant at 37°C
(Fig. 3C, lane 8), and which has previously
been characterized as Man-Man-GlcN-
(acyl)PI (7). The mcd4/TbGPI10 strains do
not accumulate lipid 031b (Man-Man-Man-
(EtN-P) M a n - G l c N - ( a c y l )PI), an
intermediate containing 3 mannoses and
accumulating in Gpi13p-depleted strains (24),
and they make no M4/1 (Man-(EtN-P)Man-
Man-(EtN-P)Man-GlcN-(acyl)PI), typical
of gpi7 strains (Fig. 3C, lane 7). The
presence of the abnormal lipid 4c in
mcd4/TbGPI10 indicated that TbGpi10p was
rather inactive under the in vitro conditions
used here. This is confirmed by the fact that
the gpi10/TbGPI10 strain accumulates M2*
(Fig. 3C, lane 6; open circle), a lipid
previously characterized as Man-(EtN-
P)Man-GlcN-(acyl)PI (25). (Interestingly,
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traces of a lipid migrating to the position of
M4* are visible in T1 and T3, but not T2 and
T4, and the same lipid is also present in
gpi10/TbGPI10 (Fig. 3C, lanes 1, 3, 6;
asterisk). This potential M4* correlate was
only observed in microsomes from MET17, not
in met17 strains and the difference may be
related to different expression levels of
TbGpi10p.)
Incorporation of [3H]inositol into proteins is a
measure of GPI protein biosynthesis and was
found to be markedly reduced in
mcd4/TbGPI10 (Fig. 3D). Most affected were
the mature proteins, which, after glycan
elongation in the Golgi, appeared as a high
molecular weight smear. Their absence
suggests that mcd4/TbGPI10 cells may have
difficulty in transporting proteins to the Golgi
(see below).
Immature GPI prote ins
accumulate in the mcd4/TbGPI10
To see if GPI lipids are transferred onto GPI
proteins at a normal rate, we analyzed the GPI
protein Gas1p, whose ER form migrates at 105
kDa and whose mature form, produced by
elongation of N- and O-glycans upon arrival in
the Golgi, migrates at 125 kDa by SDS-PAGE.
As long as a GPI anchor is not added to Gas1p
in the ER, the protein is not packaged into
COPII vesicles and not transported to the
Golgi so that it accumulates as an immature
105 kDa form (26, 27). Indeed, any significant
reduction of GPI lipid biosynthesis leads to an
increase of the immature 105 kDa form of
Gas1p (28). A previous report shows that the
ER-to-Golgi transport of Gas1p is blocked in
the mcd4-174 mutant at restrictive temperature
while transport of other proteins such as CPY
is unaffected (8). As can be seen in Fig. 4A, in
mcd4 /TbGPI10 cells the mature 125 kDa
Gas1p was less abundant than in
corresponding wt cells while the immature 105
kDa form was present in normal or increased
amounts (see below). Moreover, the mutant
cells did not accumulate the typical ER and
Golgi proforms of CPY named p1 and p2,
respectively, and the mature vacuolar form of
CPY was present in normal amounts. The p1
proform of CPY was however drastically
increased in the s e c 1 8 secretion mutant
incubated for 1h at 37°C (not shown). This
suggested that the defect of mcd4/TbGPI10
only affects GPI prote ins . The
mcd4/TbGPI10 cells release Gas1p into the
medium (Fig. 4B), and this phenomenon is
only partially explained by cell lysis, as
relatively less immature Gas1p is found in the
medium than in the cells. Release of mature
GPI proteins could be shown more clearly for
Yap3p (see below).
To assay the rate of transport of immature
Gas1p to the Golgi, the amount of immature
Gas1p was also determined after incubation of
cells with cycloheximide (CHX). As shown in
Fig. 5A, the relative amounts of immature
Gas1p (sum of aqueous and detergent phases)
is reduced five fold during a 20 min incubation
in the presence of CHX in T1 wt cells (from 10
down to 2 %), while in the mutant T3 only a
small fraction of immature Gas1p disappears
(from 49% down to 40%). Thus, immature
Gas1p seems to be transported only very
slowly out of the ER in the mcd4/TbGPI10
mutant. As mentioned above, GPI-proteins
accumulate in the ER when they fail to be
anchored but accumulation of GPI proteins in
the ER is also observed in other instances: the
transport of GPI proteins to the Golgi also fails
if COPI, or sphingolipid biosynthesis, or the
Emp24p complex, or yet other factors are
deficient (for review see (29)). To see if the
immature Gas1p accumulat ing in
mcd4 /TbGPI10 is anchored or not, we
partitioned Gas1p before and after PI-PLC
treatment in the detergent Triton X-114 (30).
Figure 5B indicates that the percentage of
immature Gas1p that partitions into the
aqueous phase due to the action of PI-PLC
treatment is higher in mcd4/TbGPI10 than in
wt cells (62 vs. 50%). (It should be noted that
it is difficult to shift the total of GPI proteins
into the aqueous phase by this technique. In
Fig. 5B, even for the mature, GPI-anchored
form, only a fraction could be shifted, namely
37% in wt and 42% in mcd4/TbGPI10).
Importantly, as the percentages of Gas1p
shifted by PI-PLC from detergent to aqueous
phase are higher for immature than for mature
Gas1p, there is no indication that immature,
non-anchored Gas1p, would be accumulating,
neither in wt nor in mcd4/TbGPI10 mutant
cells. There are reports showing that during
Triton X-114 solubilization at 4°C, part of
GPI-anchored proteins are recovered in the
detergent-insoluble pellet. The efficiency of
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solubilization in our experiment was evaluated
by probing equivalent samples of the
detergent-insoluble pellet and the detergent
extract (Fig. 5C). Although Triton X-114 only
solubilized 62 % and 80% of Gas1p in wt and
mutant cells, respectively, immature Gas1p
was solubilized nearly quantitatively in both
strains. Thus, the results obtained in Figs. 5A
and 5B are representative for the total of
immature Gas1p. Pulse chase analysis
confirmed the severe transport block of Gas1p
(Fig. 5D).
To generalize the data obtained with Gas1p we
also investigated the fate of another GPI
protein, Yap3p (Yps1p). Yap3p, a 570 amino
acids long protein containing 10 potential N-
glycosylation sites was described as a 68 kDa
GPI-anchored protein (31), but in other reports
using the same antibodies, the immature forms
of this protein ran as 80 kDa (32) or as 80 and
100 kDa proteins (33) or as bands at 85 and
115 kDa (34), whereas mature forms ran as a
broad smears around 150-200 kDa. As can be
seen in Fig. 6A, the mcd4/TbGPI10 mutant
(T4) contained much less of the mature (140 -
240 kDa) Yap3p form than the wt (T2) strain
or the gpi1 mutant, but it accumulated an
immature 75-100 kDa ER form. Further
analysis showed that, similar to Gas1p, Yap3p
was secreted from cells into the medium (Fig.
6B). Significantly, the secreted Yap3p
consisted mainly of mature Yap3p whereas in
the cell lysate, the mature form of Yap3p was
relatively minor. Thus, it seems that the
appearance of Yap3p in the culture medium of
mcd4/TbGPI10 cells is not due to cell lysis
but rather the secretion of a mature Yap3p
form. Secretion of GPI proteins has previously
been noted in gpi mutants, e.g. in gpi3 (35).
GPI anchoring of Yap3p was tested using PI-
PLC and TX-114 partitioning as done for
Gas1p in Fig. 5B. About 60 % of the mature
Yap3p could be shifted from detergent to
aqueous phase by PI-PLC in the wt as well as
the mutant (Fig. 6C). Again, the
mcd4/TbGPI10 mutant T3 showed a strong
accumulation of 75 and 95 kDa ER forms and
only 7 % of this material could be shifted from
the detergent to the aqueous phase by PI-PLC,
as the bulk of it partitioned to the aqueous
phase even after mock treatment. (It should be
noted that in Fig. 6C the amount of immature
Yap3p is severely underestimated, because PI-
PLC treatment was done with the Triton X-114
detergent phase and the bulk of the immature
Yap3p had already been lost into the aqueous
phase of the initial phase separation done to
produce this detergent phase that was then
treated with PI-PLC). Low amounts of the
same 75 and 95 kDa ER forms were visible in
the detergent phase of wt cells and were
efficiently shifted from the detergent to the
aqueous phase by PI-PLC (Fig. 6C, not
quantitated). The region <65 kDa contains
non-specific bands. During CHX treatment, the
75-95 kDa ER forms vanished in wt cells, but
not in mcd4/TbGPI10 cells (not shown). A
control analogous to Fig. 5C showed that
Triton X-114 had quantitatively extracted
Yap3p form T3 while a small percentage of
mature Yap3p of T1 remained in the pellet (not
shown). We interpret these results as to mean
that Yap3p, quite in contrast to Gas1p, fails to
be anchored efficiently in mcd4/TbGPI10 and
accumulates in an unanchored form in the ER.
This interpretation is based on the observation
that non-anchored Gas1p partitions into the
aqueous phase during Triton X-114 phase
separation (30, 36) and the assumption that the
same may hold for unanchored Yap3p. To
summarize, in mcd4/TbGPI10 cells, Yap3p
accumulates in the ER, a small amount is
anchored and remains cellular, a larger part
travels through the Golgi and ends up in the
medium. It is presently unclear if that latter
material is first anchored but secreted because
its structurally abnormal anchor is hydrolyzed
at the cell surface, or if this material is
transported through the Golgi in an
unanchored form.
The mcd4/TbGPI10 cells do not
introduce ceramides into their
GPI anchors in the ER
The mature GPI proteins contain a different
lipid moiety than the primary GPI lipid, which
is attached to them after they have entered the
ER. This primary GPI lipid probably contains
the C16 and C18 fatty acids typically found in
phosphatidylinositol in yeast (37). Most
mature GPI proteins of yeast contain a
ceramide moiety, whereas a minor fraction
contains a modified diacylglycerol containing
C26:0 in sn2 (34, 37, 38). Thus, all mature GPI
proteins of yeast endowed with lipid moieties
containing C26 or hydroxylated C26 fatty
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acids, and the mature lipid moieties are
introduced by a remodeling step that replaces
the primary lipid moiety. As shown in Fig. 7,
lanes 5 - 7, T1 and T2 MCD4/TbGPI10 cells
make a normal set of anchor lipids, namely
pG1, a C26:0-containing PI species migrating
slightly faster than the abundant PI present in
the lipid extract of wt cells (lane 4), and IPC/B
and IPC/C, containing PHS-C26:0 and PHS-
C26:0-OH, respectively. In contrast, T3 and T4
mcd4/TbGPI10 cells make only pG1, but no
IPCs (Fig. 7, lanes 8, 9). Their ceramide
biosynthesis however must be normal since
they make a normal set of sphingolipids (Fig.
7, lanes 1 - 3), although in lower than normal
quantities. This probably is a consquence of
the slower growth rate and a concomitant
slowing of the transfer of [ 3H]inositol-
phosphate from PI to ceramide.
Cell wall biogenesis and bud site
selection are defective in
mcd4/TbGPI10 cells
Many mutations in the GPI biosynthesis
pathway cause cell wall fragility, for which the
cell tries to compensate by inducing chitin
biosynthesis, and cells therefore become
hypersensitive to calcofluor white, a chitin
binding toxic compound. mcd4 mutants being
affected in GPI biosynthesis not unexpectedly
display osmotic sensitivity and lysis in
hypotonic media, increased sensitivity to
calcofluor white, SDS, zymolyase, caffeine
and staurosporine, an inhibitor of Pkc1p (17,
39). As shown in Figs. 8A and 8B,
mcd4/TbGPI10 cells were hypersensitive to
calcofluor white, caffeine, and neomycin and
also were unable to survive a sudden heat
shock (Fig. 8C). In spite of these several signs
of cell wall fragility, mcd4/TbGPI10 cells
didn't display any hypersensitivity to SDS and
were not hypersensitive to staurosporine (not
shown), suggesting that the cells are
osmotically competent . Thus, certain
symptoms of cell wall fragility are present in
mcd4/TbGPI10 cells but others, typically
present in mcd4 mutants, are absent. The
m c d 4 / T b G P I 1 0 cells also were Cu2+
hypersensitive (Fig. 8B), while certain mcd4
alleles had been shown to be copper resistant
(15).
Compared to wt cells, the mcd4/TbGPI10
cells are unusually large and grow in small
clumps of round cells (not shown). A similar
phenotype of abnormally large and round cells,
growing in small clumps because of a cell
separation defect, has been described in a
mcd4 mutant and has been attributed to its
inability to polarize its secretion apparatus (14,
17). Microscopic inspection of haploid
mcd4/TbGPI10 cells after calcofluor white
staining indicated that cells have only slightly
more chitin in their cell walls than wt cells but
that they have a defect in axial bud site
selection. Many cells, in stead of the normal
axial, showed a bipolar, or unipolar or random
bud site selection pattern (Fig. 9A). The same
bud site selection defect was equally seen
when cells were grown in minimal medium but
in this medium they also had more chitin all
over their cell walls (not shown). As a positive
control we used elo3 cells, which do not
show the normal axial pattern but exhibit a mix
of bipolar, unipolar and random bud site
selection patterns (Fig. 9B) (40). Transfection
of mcd4/TbGPI10 with a plasmid harboring
the wt MCD4 gene abolished the bud site
selection defect, since buds faithfully emerged
next to the previous bud emergence site (Fig.
9A).
The same bud selection defect was also found
in the mcd4ts strain grown at semi-permissive
temperature (32° and 34°C)(Fig. 9B). These
mutant cells additionally exhibited a
deregulated bud emergence generating
multibudded cells (Fig. 9B), a phenomenon
which was only very occasionally observed in
mcd4/TbGPI10. The gpi7 and gpi1 mutants
(Fig. 1), lacking an EtN-P on Man2 or being
unable to make GPI anchors at elevated
temperatures (41) did not exhibit any bud site
selection defect (Fig. 9B), although gpi1
mutants generate multibudded cells (41).
These findings suggest that bud site selection
is not just dependent on the synthesis of
sufficient amounts of GPI proteins but
specifically depends on the EtN-P on Man1.
Discussion
Our report shows that the essentiality of MCD4
in yeast can be suppressed by the presence of
T. brucei GPI10, an enzyme that allows the
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completion of GPI lipids beyond the stage of
the Man2-GlcN-acyl-PI intermediate that has
been shown to accumulate in mcd4ts mutants
(7). This reconfirms the previously postulated
importance of the EtN-P side chain on Man1
for yeast Gpi10p and the correctness of the
idea that MCD4 is required for addition of
Man3 because it allows the biosynthesis of the
correct substrate for Gpi10p (9, 11). The
resulting mcd4/TbGPI10 yeast strain grows
more slowly than wt and shows various
abnormalities in the biosynthesis and transport
of GPI proteins but it would appear that neither
the enzymes required to transform the Man3-
GlcN-acyl-PI into a mature GPI nor the
transamidase have an absolute requirement for
a EtN-P on Man1 (Fig. 1). In contrast to yeast,
the human MCD4 ortholog PIG-N is not
required for the survival of tumor cell lines in
vitro (9). In vivo metabolic labeling with [3H]-
mannose of PIG-N knock out (KO) cells shows
that the GPI biosynthesis stops at H7'
(mammalian equivalent of M4*) instead of H8
(mammalian equivalent of CP2), but
quantitatively there is not more H7' in PIG-N
KO cells than there is H8 in wt cells, while
transamidase mutants such as the hGAA1 KO
cells accumulate massive amounts of H8 and
of earlier GPI intermediates (9). Although
these KO tumor cell lines may be genetically
unstable and therefore not truly comparable
amongst each other, one naively may interpret
the above findings to mean that the human
transamidase uses GPI lipids lacking EtN-P on
Man1 quite efficiently, or else, that the
transamidase is absolutely not rate limiting in
the mammalian system. In contrast, the
accumulation of M4* in mcd4/TbGPI10 cells
(Fig. 3A) suggests that yeast transamidase does
not work efficiently with GPI lipids lacking
EtN-P on Man1 or else, that the GPI
transamidase of mcd4/TbGPI10 cells is
blocked by anchored GPI proteins, which
accumulate because they are not efficiently
transported to the Golgi. These two
possibilities are not mutually exclusive. The
latter idea is however less likely, since no
accumulation of CP2 can be observed in sec18
at 37°C, which accumulate GPI anchored
proteins in the ER due to a secretion block
(42). Thus, we believe that the transamidase is
working more slowly in mcd4/TbGPI10
because M4* is not its optimal substrate. This
is also supported by the finding that the
amount of [3H]inositol-labeled proteins is
severely reduced (Fig. 3D), and that a certain
GPI proteins accumulate as unanchored ER
forms. Intriguingly, this was only observed
with Yap3p, while Gas1p was efficiently
anchored. How can we explain this different
fate of Gas1p and Yap3p?
The quality of the GPI attachment signal and
hence the probability that a protein will be GPI
anchored can be calculated using the
algorithms elaborated by Birgit Eisenhaber and
c o w o r k e r s d i s p l a y e d a t
http://mendel.imp.univie.ac.at/home/Birgit.Eis
enhaber/index.html. The predictor for fungi
gives GPI anchoring probability scores
between 5 and 20 for most of the ascertained
GPI proteins of yeast, a score of 13.7 for
Gas1p, but a score of only 0.65 for Yap3p.
Nevertheless, data in Fig. 6C indicate that in
wt cells (T1) at least 59% of Yap3p are GPI
anchored confirming an earlier report by others
(31). The available microsomal assays for the
GPI transamidase allowed to establish that the
Gpi8p protease attacks the  residue, thereby
allowing the C-terminal anchor attachment
signal to leave and forming a covalent acyl
intermediate, which in turn is attacked by the
GPI lipid to release the enzyme. It is
conceivable that the binding of GPI lipid and
protein substrate to the enzyme is cooperative
and that low score GPI proteins such as Yap3p
are more dependent on this cooperative effect
for efficient anchoring than high score proteins
such as Gas1p. Thus, we speculate that in
mcd4/TbGPI10 cells the lack of appropriate
GPI lipids may lead to a deficiency of GPI
anchoring, which specifically affects low score
proteins.
In yeast, the reduced surface expression of GPI
proteins in mcd4/TbGPI10 can be traced to
several reasons, depending on the protein:
Gas1p seems to be inefficiently transported
and, in addition, to be lost into the medium,
Yap3p also is lost from the surface and
additionally is not anchored efficiently. The
analysis of the lipid anchor of Gas1p only
identified fatty acids but no ceramide (38);
thus, the lack of ceramide remodeling cannot
directly be responsible for the failure of
mcd4/TbGPI10 cells to transport Gas1p from
the ER to the Golgi. One possiblity is that EtN-
P on Man1 is required for the interaction of
Gas1p with the cargo receptor Emp24p, which
was shown to physically interact with Gas1p
(43).
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The complete absence of ceramide anchors in
mcd4/TbGPI10 cells suggests that, similar to
GPI10, the hypothetical ceramide remodelase
requires the presence of EtN-P on Man1.
Alternatively, it also may be that, beyond
being the EtN-P transferase, MCD4 also acts
as a ceramide remodelase, capable of
exchanging diacylglycerol for ceramide.
Indeed EtN-P transferase and remodelase
reactions are similar in that both represent
transterification reactions involving
phosphodiester linkages. The possibility that
Mcd4p acts as ceramide remodelase is also
supported by the fact that the deletion of GPI7
(Fig. 1) leads to a specific defect of ceramide
remodeling in the Golgi (23). This possibility
is presently further investigated.
MCD4 mutants were isolated in many different
contexts and found to be deficient in many
apparently unrelated biological functions. As
the mcd4/TbGPI10 cells not only lack EtN-P
on Man1 of the GPI anchored proteins, but
also exhibit a severe reduction of many GPI
proteins on their surface, we tried to compare
their phenotype with the ones of the few other
viable gpi mutants hoping to identify some
characteristics that may give us a hint about a
more specific function of the EtN-P on Man1
and the introduction of ceramide into the GPI
anchors in the ER. Such a specific function
was recently suggested for the EtN-P on Man2,
added by Gpi7p: Lack of EtN-P on Man2 leads
to a missorting of the daughter cell specific,
GPI-anchored endoglucanase Egt2p (44). We
started to investigate this phenotype in
mcd4 /TbGPI10 , but abandoned because
>90% of the HA-tagged Egt2p was secreted by
both wt (T1) and mcd4/TbGPI10 (T3) in the
form of a 65 kDa fragment (reducing SDS-
PAGE) rather than the expected >100 kDa
form (not shown).
We find a distinct bud site selection defect in
all mcd4/TbGPI10 cells. While many genes
are known to affect the bipolar bud site
selection in diploid cells, much fewer genes
are known to affect the normal axial budding
pattern of haploid cells, and the two classes of
genes are largely non-overlapping (45). Of the
few genes related to GPI protein expression,
the deletion of GAS1, CCW12, BST1 and GPI7
affect only bipolar bud site selection in
diploids, but were found to be without any
effect on budding in haploid cells (40).
Obviously, if GPI anchoring were required for
bud site selection, this may easily have been
overlooked, as most deletion mutants in the
GPI anchor biosynthesis pathway of yeast are
lethal. Here we report on a bud site selection
defect of mcd4 /TbGPI10. This finding
suggests that some GPI anchored protein(s)
may be important for bud site selection in
haploids. At the same time our data show that
haploid gpi7 and gpi1 and bst1 mutants
don't exhibit a similar defect (Fig. 9B)(40).
Further work is necessary to firmly establish
and understand the specific role of the EtN-P
side chain on Man1 in axial bud site selection.
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Figure legends
Figure 1: Structure of the complete GPI precursor lipid CP2. P = phosphate. The genes required
for adding the EtN-P side chains and Man3 are indicated; yeast genes are in italics. Treatment of the
lipid CP2 with hydrofluoric acid (HF), nitrous acid (HNO2), and PI-PLC leads to hydrolysis at
indicated sites.
Figure 2: T. brucei Gpi10p can rescue viability and growth of yeast mcd4 cells. A, the
(mcd4/MCD4) diploid strain was transformed with p425-TbGPI10 carrying TbGPI10 under the
MET17 promoter and was sporulated. One complete tetrad is shown. B, the genotype of strains T1 -
T4 derived from the tetrad shown in panel A was evaluated by plating on methionine drop out and
G418 plates. C, PCR analysis of the DNA of strains T1 - T4 and the parental mcd4/MCD4 diploid
(P). The picture shows the homology regions of primers on the target DNA and the results of the PCR
reactions done with various primer combinations as indicated. D, ten fold dilutions of T2 or T4 cells
were plated on SDaaUA plates containing 2 mM ethanolamine (EtN), 50 mg/L inositol (Ins), 2 mM
choline (C), 1 M sorbitol (Sor) alone or in combination. Plates were incubated at 37°C for 6 days.
Figure 3. mcd4/TbGPI10 cells accumulate M4*. A, Cells were labeled with [3H]inositol
(4 μCi/A600) at 24°C (T1 - T4) or 37°C (gpi7 and sec18 gpi8) for 120 min. Desalted lipid extracts
were analyzed by TLC using solvent CHCl3:CH3OH:H2O (10:10:3) and fluorography. The same
amount of radioactivity was spotted in each lane. Total incorporation into lipids was 24% in T1 and
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T2, 17% in T3 and T4, 50% in gpi7 cells and 41% in gpi8 sec18. The small amounts of label
comigrating with CP2 are due to incomplete desalting resulting in the presence of residual free
[3H]inositol (lane 1), which in this TLC run comigrated with CP2. B, lipid M4* of panel A was
scraped off the plate, and the core glycan moiety was prepared using HF dephosphorylation. The N-
acetylated glycan fragment was analyzed by paper chromatography and radioactivity was determined
in 1 cm wide strips using scintillation counting. Certain standards (Std.) were run in parallel (M1-M4
= Manx-GlcNAc-Inositol, x being 1, 3 or 4) while [
14C]inositol was mixed with the M4* test sample
and its position is given by a vertical arrow (Ins). Free inositol contaminating the test sample may
derive from partial degradation by HF. C, all cells were grown at 24°C and gpi7, mcd4ts and its
corresponding MCD4 wt strain were further incubated for two hours at 37°C. The cells were lysed and
microsomes were prepared and incubated with UDP-[3H]GlcNAc, GDP-Man, tunicamycin,
nikkomycin, CoA and ATP for 1.5 h at the temperature used for the preculture. Lipids were extracted,
desalted and analyzed by TLC as above. Lipids 4c and 031b are marked with open triangles and a
circle, respectively.D, proteins remaining after lipid extraction in the experiment of panel A were
analyzed by SDS-PAGE and fluorography.
Figure 4. The mcd4/TbGPI10 cells contain reduced amounts of mature Gas1p. A, T1 to T4 cells
and the parental BY4742 cells were cultured in YPDUA at 30°C, protein extracts were prepared (19)
and processed for Western blotting using antibodies against Gas1p and CPY and developed using the
LI-COR system. The positions of mature (m), immature (i) and unprocessed precursors (p1, p2) are
indicated. B, cells were grown in YPDUA at 30°C, media (M) and cell lysates (C) (solubilized with
octyl--glucoside) were processed for Western blotting using anti-Gas1p antibodies and the ECL
system.
Figure 5. GPI-anchored Gas1p is not efficiently transported from the ER to the Golgi in
mcd4/TbGPI10. A, 100 μg/ml cycloheximide (+CHX) or water (-CHX) were added to exponentially
growing MCD4/TbGPI10 (T1) or mcd4/TbGPI10 (T3) cells. After 20 min at 30 °C, the cells were
lysed and proteins were solubilized with TX-114. After sedimenting at 16'000g for 5 min to remove
insoluble material the supernatant was warmed to 37 °C and detergent (D) and aqueous (A) phases
were separated and analyzed by Western blotting with anti-Gas1p antibody. The percentage of
immature relative to total Gas1p, taking into account the sum of both phases, is indicated (%i). B,
aliquots of the detergent phases from cells not incubated with CHX were diluted and incubated in the
presence (+) or absence (-) of PI-PLC (PLC) to remove anchor lipids (Fig. 1). After incubation the
samples were again separated into aqueous (A) and detergent (D) phases and were processed for
immunoblotting as above. The percentage of Gas1p present in the aqueous (A) phase compared to the
Gas1p in both (A + D) phases is indicated on separate lines for mature (%Am) and immature (%Ai)
forms of Gas1p. C, the insoluble pellet (P) and the soluble supernatant (S) obtained during the initial
16'000g spin (see legend for panel A) were processed for immunoblotting as above. Material
corresponding to equivalent amounts of cells was loaded. Blots of panels A - C were visualized using
the LI-COR system. D, cells were labeled with [35S]methionine/cysteine for 12 min and chased for 0
or 40 min. Gas1p was immunoprecipitated and analyzed by immunoprecipitation and autoradiography.
Sec18 cells were labeled at 37 °C, where they are unable to transport proteins out of the ER.
Figure 6. Yap3p is not efficiently anchored in mcd4/TbGPI10. A and B, the lysates (A) and media
(B) as used for Fig. 4B as well as lysates and media of gpi1 and yap3 prepared in parallel were
analyzed for the presence of Yap3p by Western blotting. Gpi1 cells were grown at 24°C, incubated
for 2 h at 37°C and lysed. An unspecific band (u) is pointed out. C, samples analyzed in Figs. 5A and
5B were also probed with anti-Yap3p antibodies and data were quantitated and expressed as in Fig.
5B.
Figure 7. No ceramides are incorporated into the GPI anchors in mcd4/TbGPI10. BY4742 (wt)
as well as T1 - T4 cells were labeled with [3H]inositol, and the lipids were extracted with organic
solvent; the protein pellets were further delipidated, GPI proteins were partially purified, digested with
pronase and the thus generated GPI anchor peptides were subjected to HNO2 treatment (Fig. 1) in
order to release the labeled lipid moiety of the anchors. Lipid extracts of the cells (lanes 1 - 4) and
anchor lipids (lanes 5 - 9) were separated by TLC using solvent CHCl3:CH3OH:0.25% aqueous KCl
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(55:45:10 for lanes 1-3; 55:45:5 for lanes 4-9) and processed for fluorography. No lipids were seen
when the HNO2 treatment was omitted (lane 5), indicating that anchor peptides were not contaminated
by free lipids. One of two experiments giving the same result is shown.
Figure 8. Growth characteristics and hypersensitivities of mcd4/TbGPI10. A, serially 10 fold
diluted T1 (wt) and T3 (mutant) cells were plated onto SDaaUA leu- met- drop out medium with or
without 50 μg/ml calcofluor white and incubated for 4 days at 30°C. B, ten fold dilutions of
exponentially growing cells were plated on YPDUA containing different inhibitors and incubated at
30°C for 3 days, except for plates containing Cu2+ which were incubated at 24°C. C, exponentially
growing cells were streaked out on YPDUA plates preheated to 55°C. Thereupon the plates were first
incubated for 45 min at 55°C, then for 3 days at 30°C.
Figure 9. mcd4/TbGPI10 cells have a bud site selection defect. A and B, cells were kept in
continuous culture at 30 °C during 10 generations and stained with calcofluor white and photographed.
The prevalent types of scar patterns are shown. The mcd4ts cells were grown at semipermissive
temperatures (32 or 34°C). The gpi1 mutant grows at 30°C but is unable to grow at 32°C.
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